Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Bellerophon, Bioxytran, CSL Vifor, Everest Medicines, Hinova Pharmaceuticals, Inmagene, Medicinova, Takeda.